Super Fund Lookup is the ATO's external register of Self-Managed Super Funds' (SMSF) current compliance statuses. Employers can utilise this service to determine whether employer contributions qualify as superannuation guarantee payments.
Valsartan and hydrochlorothiazide is manufactured by Novartis Pharmaceuticals. Valsartan and hydrochlorothiazide is a combination of two medicines -- valsartan and hydrochlorothiazide. Valsartan is a newer type of blood pressure medicine known as an angiotensin II receptor blocker, or ARB for short.
1 tablet/day PO (80-160 mg valsartan/12.5-25 mg hydrochlorothiazide); may be titrated after 1-2 weeks of therapy; not to exceed 320 mg valsartan/25 mg hydrochlorothiazide daily. Safety and efficacy not established.